Mirae Asset Global Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $483K | Buy |
8,795
+1,127
| +15% | +$62K | ﹤0.01% | 948 |
|
|
2025
Q1 | $548K | Buy |
7,668
+78
| +1% | +$5.57K | ﹤0.01% | 910 |
|
|
2024
Q4 | $507K | Sell |
7,590
-814
| -10% | -$54.3K | ﹤0.01% | 945 |
|
|
2024
Q3 | $593K | Buy |
8,404
+1,167
| +16% | +$82.4K | ﹤0.01% | 934 |
|
|
2024
Q2 | $604K | Sell |
7,237
-100,844
| -93% | -$8.42M | ﹤0.01% | 887 |
|
|
2024
Q1 | $9.83M | Buy |
108,081
+56,784
| +111% | +$5.17M | 0.02% | 646 |
|
|
2023
Q4 | $4.95M | Sell |
51,297
-50,979
| -50% | -$4.92M | 0.01% | 895 |
|
|
2023
Q3 | $9.05M | Buy |
102,276
+1,359
| +1% | +$120K | 0.02% | 652 |
|
|
2023
Q2 | $8.75M | Sell |
100,917
-100,848
| -50% | -$8.75M | 0.02% | 707 |
|
|
2023
Q1 | $19.6M | Buy |
201,765
+98,818
| +96% | +$9.61M | 0.05% | 407 |
|
|
2022
Q4 | $10.7M | Sell |
102,947
-17,990
| -15% | -$1.86M | 0.03% | 580 |
|
|
2022
Q3 | $10.3M | Buy |
120,937
+12,409
| +11% | +$1.05M | 0.03% | 565 |
|
|
2022
Q2 | $8.99M | Sell |
108,528
-30,542
| -22% | -$2.53M | 0.02% | 636 |
|
|
2022
Q1 | $10.7M | Sell |
139,070
-24,177
| -15% | -$1.86M | 0.02% | 650 |
|
|
2021
Q4 | $14.4M | Buy |
163,247
+12,550
| +8% | +$1.11M | 0.03% | 566 |
|
|
2021
Q3 | $11.6M | Buy |
150,697
+29,653
| +24% | +$2.29M | 0.03% | 585 |
|
|
2021
Q2 | $10.1M | Buy |
121,044
+27,156
| +29% | +$2.27M | 0.03% | 626 |
|
|
2021
Q1 | $7.09M | Buy |
93,888
+35,280
| +60% | +$2.66M | 0.02% | 649 |
|
|
2020
Q4 | $5.14M | Sell |
58,608
-16,459
| -22% | -$1.44M | 0.02% | 648 |
|
|
2020
Q3 | $5.71M | Buy |
75,067
+15,502
| +26% | +$1.18M | 0.03% | 522 |
|
|
2020
Q2 | $7.35M | Buy |
59,565
+10,984
| +23% | +$1.35M | 0.04% | 401 |
|
|
2020
Q1 | $4.11M | Buy |
48,581
+6,948
| +17% | +$587K | 0.03% | 479 |
|
|
2019
Q4 | $3.52M | Buy |
41,633
+7,913
| +23% | +$669K | 0.02% | 593 |
|
|
2019
Q3 | $2.27M | Buy |
33,720
+7,582
| +29% | +$511K | 0.02% | 674 |
|
|
2019
Q2 | $2.23M | Buy |
26,138
+4,216
| +19% | +$359K | 0.02% | 668 |
|
|
2019
Q1 | $1.94M | Buy |
21,922
+2,098
| +11% | +$186K | 0.01% | 654 |
|
|
2018
Q4 | $1.69M | Buy |
19,824
+2,753
| +16% | +$234K | 0.02% | 645 |
|
|
2018
Q3 | $1.66M | Buy |
17,071
+3,431
| +25% | +$334K | 0.01% | 698 |
|
|
2018
Q2 | $1.27M | Buy |
13,640
+1,918
| +16% | +$178K | 0.02% | 467 |
|
|
2018
Q1 | $951K | Buy |
11,722
+341
| +3% | +$27.7K | 0.01% | 504 |
|
|
2017
Q4 | $1.02M | Buy |
11,381
+1,030
| +10% | +$91.9K | 0.01% | 474 |
|
|
2017
Q3 | $963K | Buy |
10,351
+2,300
| +29% | +$214K | 0.02% | 430 |
|
|
2017
Q2 | $727K | Buy |
8,051
+1,567
| +24% | +$141K | 0.01% | 432 |
|
|
2017
Q1 | $569K | Buy |
6,484
+3,642
| +128% | +$320K | 0.01% | 443 |
|
|
2016
Q4 | $235K | Sell |
2,842
-1,884
| -40% | -$156K | 0.01% | 484 |
|
|
2016
Q3 | $437K | Sell |
4,726
-1,618
| -26% | -$150K | 0.01% | 463 |
|
|
2016
Q2 | $494K | Buy |
6,344
+217
| +4% | +$16.9K | 0.01% | 403 |
|
|
2016
Q1 | $505K | Buy |
6,127
+282
| +5% | +$23.2K | 0.01% | 388 |
|
|
2015
Q4 | $612K | Buy |
5,845
+1,589
| +37% | +$166K | 0.02% | 359 |
|
|
2015
Q3 | $448K | Buy |
4,256
+168
| +4% | +$17.7K | 0.02% | 352 |
|
|
2015
Q2 | $559K | Buy |
4,088
+284
| +7% | +$38.8K | 0.02% | 364 |
|
|
2015
Q1 | $474K | Buy |
3,804
+312
| +9% | +$38.9K | 0.02% | 374 |
|
|
2014
Q4 | $316K | Buy |
3,492
+2
| +0.1% | +$181 | 0.01% | 387 |
|
|
2014
Q3 | $252K | Buy |
+3,490
| New | +$252K | 0.01% | 426 |
|
|
2013
Q3 | – | Sell |
-10,362
| Closed | -$578K | – | 407 |
|
|
2013
Q2 | $578K | Buy |
+10,362
| New | +$578K | 0.03% | 326 |
|